DatasetName,ATP2A2_S(10) ATP2A2_S(12) ATP2A2_S(13) ATP2A2_S(184) ATP2A2_S(21) ATP2A2_S(3) ATP2A2_S(38) ATP2A2_S(4) ATP2A2_S(473) ATP2A2_S(5) ATP2A2_S(6) ATP2A2_S(608) ATP2A2_S(649) ATP2A2_S(663) ATP2A2_S(8) ATP2A2_S(9) ATP2A2_T(11) ATP2A2_T(191) ATP2A2_T(3) ATP2A2_T(4) ATP2A2_T(537) ATP2A2_T(648) ATP2A2_Y(5),ATP2A2_C(383) ATP2A2_S(15) ATP2A2_S(186) ATP2A2_S(555) ATP2A2_S(580) ATP2A2_S(609) ATP2A2_T(181) ATP2A2_T(499) ATP2A2_Y(497),ATP2A2_S(378) ATP2A2_S(538) ATP2A2_S(553)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.556202632786759,0.44363230557199274,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.555538146273052,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5492693494419121,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5558477297609544,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.559182402648135,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.5556330208415582,0.45019586072999407,
RB2022_5_PreEndurance,0.5768828196111498,0.4725843556769186,0.6247573791136061
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5595974929790365,,
WZ2023_Pu_010_30min,0.5606146237139068,0.45116032244360554,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.5640976830145515,0.4467015827679097,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,0.5496924585909029,,
KBE2022_Log2_Ex_14_U,0.5576553332299956,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.5637900367528609,,
RB2022_5_PreSprint,0.5464008363687451,,
PG2020_Intensity 8h_C,0.5573914418336942,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.560445314642556,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.5654100595463644,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5547968524975473,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.5558601356250771,0.4325060083594939,0.6115808386548388
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5442893637010294,,
GF2025_P6_Sph,0.5583039644029465,,
RB2022_2_PreSprint,0.5705718297556236,0.45606734596011766,
ZX2022_CB treated Replicate 3,0.5500670239659206,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5601603549913644,0.44276543362481363,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,0.5590388526713355,,
WZ2023_Pu_005_10min,0.5606052609017682,0.4478245576264487,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.55203368846832,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5609452097639877,0.4517079998534828,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,0.5597097032151812,0.42072201577789997,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.5537748756644251,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.5466425431706612,0.4360122594452,0.6037580165259735
EJN2021_3_Rest_Basal,0.5714106302218136,0.43404837453679296,0.6784084702568571
CR2017_Ratio Replicate 1.3,0.5512962949760931,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5577475645555424,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5601483029122223,0.44506882414748383,
CK2022_11 40-1,0.5519051491558247,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,0.42861701743142944,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,0.560798684875219,0.4485718317760045,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.5548614185067989,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,0.5585854134562479,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,0.590897239126034,0.4733284898025325,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.554732316686504,,
CK2022_1 200-1,0.5587591022186189,,
PG2020_Intensity Mock_10h_D,0.5544205423857321,,
SR2019_MCF10A_Biol_repl_2,0.5613515509392835,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,0.558741216967256,0.4180167819729122,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5522504075569552,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5556640675249248,,
PG2020_Intensity 2h_C,0.5539366276328856,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5492294841222217,,
KBE2022_Log2_Ex_8_T,0.5577461867631149,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,0.5545131231088012,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,0.5526967953084319,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,0.5532588556188446,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,0.5871350356879347,0.45874076336380665,0.7104143599820576
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,0.5577898763262288,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.5929668547524052,0.4798160237722144,0.6068967671802361
RB2022_1_PostEndurance,0.5503318511715417,,
CR2017_Ratio Replicate 3,0.5554285153570794,,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.5545244825593556,,
HS2024_8_I_T3,,,
CF2017_EOC 3,0.5569098177056999,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5605549347112897,0.4496895104857567,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.5521819496358268,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.555527137592155,,
KS2014_Intensity N3,,0.4604732404488305,
RB2022_4_RecoveryEndurance,0.5551952310089846,0.44579851996855513,
RB2022_5_RecoveryEndurance,0.5530114314809932,0.456734362889497,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,0.5586833798576217,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.5618626229537648,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.5568519223691473,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5580253483625776,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5609479930000344,0.448099303789652,0.5829959795601639
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5594831890194769,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.5607955497714766,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5584372889800385,0.44844783136281485,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.5469062528062253,,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.5614163933609017,,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,0.5620799146996527,,
CK2022_14 40-1,0.5515570641274418,,
RB2022_6_PreSprint,0.556535989564698,0.441421052777008,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.556506407810318,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.5597186549279545,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,0.57003775628431,0.4542878352550519,0.6990844476021026
RN2012_H05,0.5571922934229666,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5553022631035011,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.5465262113310734,0.4282787336654683,
EJN2021_1_Rest_Ins,0.5884091799690895,0.46133336158011823,0.7354462411782925
HH2022_Reporter intensity 3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,,
GF2025_P8_Sph,0.553681065283029,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.5585195169962237,,
CK2022_12 200-1,0.5585808807709983,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,
WZ2023_Su_010_20min,0.5611323176297529,0.45292514295217434,
AH2018_TMTMS2_2_N,,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.5589825028497823,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5387267393266064,0.4442011422219534,
AH2018_TMTMS3_Pool,0.5579605753274024,,
KS2014_Intensity N4,,0.47041530201827175,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.5535151041281359,,
CK2022_14 200-1,0.5584655952314748,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.5248556178501843,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,0.5547768188643698,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.5760707578906115,0.4572766043523593,0.6893962400565874
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.5534458034962858,,
GF2025_P1_Adh,0.553253612993438,,
GF2025_P1_Sph,0.5550878818543632,,
EJN2021_5_Ex_Basal,0.5774610553716651,0.45757912000564804,0.7088984064111449
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5600900310464683,0.44567010810790936,
CF2017_EOC 1,0.5602600806235928,,
CK2022_3 200-1,0.5589533457759763,,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,0.560854559971178,0.4405722718817394,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,0.5547811932069427,0.4250678541292876,
CK2022_2 40-1,0.5520329419230418,,
RB2022_1_PostSprint,0.5346140296120813,,
CK2022_4 200-1,0.5587884416416261,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.555934184492196,,
AR2021_ALG 1 μM,0.5569292192242916,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.5889919855488779,0.46466221019122844,0.7331225776940645
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.5622067852529361,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.561000760375734,,
CK2022_9 16-1,0.5546460799464356,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.5584458778603245,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.5573187267144843,,
CK2022_16 16-1,0.5540746510771093,,
FS2019_db/db3,,,
CK2022_15 40-1,0.5512868003506596,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5603722155859533,0.44813830404706384,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.5592270023390997,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.5577486139052711,,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,0.5606484935580284,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.5448706133968536,0.43703554263049593,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.5572523420441338,0.47239355030160834,
YA2020_Reporter_intensity_Normal_No.4,0.5569820159773252,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.5556420823952013,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.5546335747909359,,
RN2012_L13,0.5511278985910565,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.5595497771351851,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.5517762322072913,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5614475551639994,,
HH2022_Reporter intensity 6,,,
RB2022_2_RecoveryStrength,0.5630880713485994,0.4366891919741125,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5604569786565301,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,0.5595424094358014,,
AH2018_TMTMS2_3_X,,,
GF2025_P3_Adh,0.5555574291241065,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5525523129899671,,
KBE2022_Log2_Ex_19_U,0.5589353819097168,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.5586852938685963,0.4544668194110909,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.5578691305198639,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),0.5617059388465279,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5573231335043529,0.4493105861243836,
RB2022_7_RecoverySprint,0.5523024256013944,0.44149641722862365,0.6306722216581779
YA2020_Reporter_intensity_Normal_No.3,0.5574653780740874,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,0.4619214873002416,
HH2022_Reporter intensity 1,,,
HH2022_Reporter intensity 2,,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5551906823476204,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,0.5519534668700901,0.44716102706020266,
CR2017_Ratio Replicate 2,0.5538128585901845,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,0.5520962620833905,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5582907666068021,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,0.5584713433078892,,
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,0.5571916487535988,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,0.5533456685167379,,
CF2017_OSE 29,0.5617303739728022,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.5599939926590838,,
RN2012_L12,0.551021189448169,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5532150365507459,,
RB2022_7_RecoveryEndurance,0.5325701854942032,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.5735169162584548,0.44992841125858934,0.684120596019158
TM2022_S2.12h.B,,,
RN2012_L15,0.5556945648421054,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,0.5568729380979182,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.5588572272731078,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,0.5629023388579191,0.4566394889561391,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.5592420092705076,,
CK2022_5 200-1,0.5594564564820641,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,0.5410229699798595,0.43583114903887155,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.5588946141890759,,
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,0.5861626220154984,0.4606418863635877,0.7133638828824216
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,0.5543775239798897,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.5764021616406126,0.45982655546907125,0.7101544449178839
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.5564478213513688,,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.5587466976935349,,
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,0.5655765442779175,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5602028754968681,,
WZ2023_Pe_025_20min,0.5598626676227472,0.44659844871003834,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,,,
RN2012_H06,0.5558652358635383,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.5606880760796297,0.44977454365743735,
SR2019_HCC1419_Biol_repl_4,0.559870173908626,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.5656176076849284,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.550176901305278,,
WZ2023_Su_025_10min,0.5605126095007193,0.44539364820566374,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.549468260371787,0.45185587879447336,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5604969238687384,0.4495185500520065,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,0.5669726586102881,0.45068160455150647,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5562700858492502,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.5491273067452842,0.43385739938314893,
KS2014_Intensity,,0.4675600323392618,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.5575361420282645,,
LY2019_P7+,0.5509940758578972,,
EP2017_Untreated R#1 normalized log2 ratio,0.5558462632939378,,
RN2012_L10,,,
PG2020_Intensity 4h_C,0.5551926915117423,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5531412849605115,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.5583752932111067,,
RB2022_8_PostStrength,0.5471962715094485,0.4128025995465559,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.558166215758629,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.555320613685599,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5583590509763239,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5520572538148533,,
GF2025_P9_Sph,0.5578508864163068,,
CK2022_6 200-1,0.5595501345073034,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,0.5553504187118127,,
EP2017_Untreated R#3 normalized log2 ratio,0.5572033029454883,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5592870363790484,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.5595814072228901,,
RB2022_7_PostEndurance,0.6027387028672804,0.49313507498812803,0.6721665484322669
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5549136084484297,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.5576642615765117,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.5891739909958918,0.46278018554698996,0.7354157965915559
FR2021_Intensity.M,,,
RB2022_2_PostSprint,0.5501390659391321,0.4619787893359899,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.5602640332907385,,
PG2020_Intensity CT_C,0.555842764759144,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.55846652656317,,
EP2017_Untreated R#3 log2 ratio,0.5570564795108657,,
RB2022_2_PostStrength,0.5373066597237516,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.5618404811563347,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,0.5698166189752626,0.46420839182503826,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.5598104401897507,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.5763507553272406,0.44995062748322745,
CR2017_Ratio Replicate 2.3,0.5603352411646657,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5568036144397166,,
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.5597011537858951,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.5580289592368158,,
CK2022_2 16-1,0.5551487037153661,,
RAM2015_Log2 B,0.5618727858849074,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.5698736412669166,0.452000791683534,0.709778616895376
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,0.5656944019121373,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,0.5520804060077136,,
WZ2023_Su_025_30min,0.5606208018034196,0.45008160963042787,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.5519651509808309,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,0.5532616515027108,0.4428468534224268,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,0.5443622850065611,0.43838420786165083,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,0.5545892622885055,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.5587712512576888,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,0.5486185632130531,0.40074141288496207,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,0.5581484749270768,0.42071662672744786,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.5729603605925779,0.4599516628219659,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.5649171447743759,,
RB2022_3_PostStrength,0.5528598513764968,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,0.5557444496717177,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.5568477731553824,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,0.5554509664303823,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.5371740240663992,,
KS2014_Intensity E15_3,,0.4311200419329222,
GF2025_P3_Sph,0.5565392066326307,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5844910253358675,0.453519329070913,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.5631834723823043,0.4418473195894862,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.5621039134043668,,
ZQ2022_N1,0.5552195441022479,,
LY2019_P6-,0.5538268097245087,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.5641800833876826,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5587910878954488,,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,0.5656112043945974,,
KBE2022_Log2_Ex_13_U,0.5583511843798751,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,0.5530171157056608,0.4263090446421558,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.5532824968768959,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,0.557181404173697,,
SR2019_BT549_Biol_repl_2,0.5563412082245727,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,0.541222971001212,0.4340971706953867,0.6064724932965326
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.5607239201205266,0.44892735192229805,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5561632179119732,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.5509320687952788,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,0.5593367677759398,,
RB2022_8_PreEndurance,0.5521417980064165,0.41484289376880396,0.6123682963117227
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.5619106872068746,0.44570476647315616,0.6753195934754591
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.5804614474743724,0.4582969371638613,0.7155349653743174
EP2017_Pervanadate R#3 log2 ratio,0.5548674198638543,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,0.5419374698598811,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.5552667866871654,,
CK2022_6 40-1,0.5532259067387034,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.5590717496237445,,
LY2019_P3-,0.5579477851166026,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.5783448629923233,0.45537517777736486,0.7042628266041514
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5601947355487138,0.44414362001351254,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.5749744775653605,0.45022419922854806,0.6982330576178842
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,0.551951917315521,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.5605939632376017,0.45179031961707466,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.5652892705903076,,
RB2022_1_RecoveryStrength,0.5659812131495005,0.45090980755630716,
SR2019_HCC1954_Biol_repl_4,0.5611002254615903,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,
RB2022_4_PreSprint,0.5544032215429062,0.433391747091919,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,0.5335941530066267,0.44163668503887554,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,0.5574492111191406,,
RB2022_2_RecoveryEndurance,0.5603950128062093,0.4523287421953823,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.5370087792319073,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.534322133348851,0.44686302030187836,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5585733606042202,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.559119948734809,,
LY2019_P2-,0.5569500935223525,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.5401245300319023,0.45260735212964714,
WZ2023_Pe_005_20min,0.5605297054306592,0.4475719167471682,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5527619202095012,,
SR2019_MCF10A_Biol_repl_4,0.5621613618174321,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.5581319319494941,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5584958321537372,,
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,0.5596627654247345,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5541673471512094,,
KBE2022_Log2_Ex_36_T,0.558392152134589,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5603978531132068,0.44967111335960513,
KS2014_Intensity C2,,0.4329285850183751,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.5584649204615558,,
CK2022_9 200-1,0.558439801074872,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5585673335974617,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5595801995488745,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5630349067233024,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,0.5593908815426395,,
EJN2021_3_Rest_Ins,0.5705822321440801,0.4496824729593815,0.6889816319932952
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5577926385717619,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5556978200881084,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.56038088004562,0.446611805590271,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,0.46296886459760916,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5553874116034355,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,0.5537929827793231,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.5536268335527527,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.5553363160862382,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,0.6158765717216554,0.48515248305492065,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5604392472163215,0.44753633111638763,
KBE2022_Log2_Ex_29_U,0.5576470948563018,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.5584724383700354,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.5588594738891592,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.5543850624145282,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.5593192923246396,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5604851795629046,0.4504678136105123,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.5767972652468961,0.4537136090983728,0.688451091085955
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5561970119372938,,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.555041740770158,,
KBE2022_Log2_Ex_44_U,0.5597159054445734,,
WZ2023_Pe_010_20min,0.5605091406500896,0.4466536820327865,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.5671241712355868,0.45041304506637503,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),0.5641545217352741,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,0.4305689396188816,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5594823252596473,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5604993151042104,0.4489494045945352,
PG2020_Intensity 6h_C,0.557596942422786,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,,
CK2022_15 16-1,0.5535618093779506,,
CK2022_3 16-1,0.5552088041442415,,
LY2019_P4-,0.5557794742491693,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.558258611360699,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5568462012390719,,
CK2022_10 16-1,0.5537199400567904,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5624705708295688,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.5649289164162107,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.5530777662297981,,
EJN2021_2_Ex_Basal,0.5741483731919591,0.4589770341781947,0.6941491506185843
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.5596768063468319,,
AR2021_L41 10 μM,0.5567562261972365,,
CF2017_EOC 2,0.5606037932576072,,
RB2022_6_PostEndurance,0.5732951157694951,0.4590474138229372,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.566819739548623,,
RB2022_7_PreSprint,0.5384125140372624,0.4506697071777012,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.555321677084676,,
ZX2022_CB treated Replicate 1,0.5489584458075977,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.547384680404442,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,
AR2021_L41 1 μM,0.5564232054144297,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5488871132564285,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5580206442192877,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.5575081570888709,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.5742218756970118,0.4604876651694444,0.597896087787508
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,0.5608987458382168,0.4496792272136336,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.5593044728695034,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5599654476964079,0.44607000882542647,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,0.4360047966880763,
ZQ2022_N3,0.5547346024370857,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5508055873890663,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5502699594674795,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.5499580866085673,,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,0.5537098107810894,,
AH2018_LFQ_3_X,,,
UK2020_UA_3,0.5657020064395085,,
LY2019_P7-,0.5513978670092484,,
GF2025_P5_Adh,0.5559903723083138,,
RB2022_1_PostStrength,0.5450242603246266,0.4285075624214116,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,0.560983089091958,,
CR2017_Ratio Replicate 2.2,0.5574058203839551,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.5540873334522572,,
ZQ2022_C1,0.5627714709497971,,
CR2017_Ratio Replicate 2.1,0.5604718957802833,,
PG2020_Intensity CT_B,0.5550520247361695,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.5555482920365425,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,0.5551965573656282,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5624662450475486,,
RB2022_2_PreEndurance,0.5678193924702536,0.45456355854025293,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.5582360546444873,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.5532785116833849,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.5609439793821623,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,0.5428972071673928,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.5636848933503935,,
EP2017_Mitotic R#2 log2 ratio,0.5531890193064101,,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,0.559215186871954,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.5843213999784818,0.45801261045652697,0.7057410731792775
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.5564981856434893,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,0.5607127794492118,,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,0.5612137736764758,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.5579352862617379,,
SR2019_HCC1419_Biol_repl_3,0.5601368164384057,,
KBE2022_Log2_Ex_14_T,0.5579864856252633,,
EP2017_Untreated R#2 normalized log2 ratio,0.5553101562015675,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5581949465213129,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5549715247933217,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
